Teduglutide Abbreviated Review

Overall, 88.3% of patients (68 of 77) treated with teduglutide 0.5 mg/kg/day experienced an adverse reaction compared to 83.1% of patients (49 of 59) on placebo.1 The following table includes a comparison of adverse reactions reported in > 5% of patients in clinical trials of patients with SBS who received teduglutide 0.05 mg/kg/day, and that ... ................
................